Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Tumani

Showing results (21-30 of 83) with videos related to

Pageof 9
Sort By:
Archives of Neurology|October 16, 1999
Glutamine synthetase in cerebrospinal fluid, serum, and brain: a diagnostic marker for Alzheimer disease?H Tumani, G Shen, J B Peter, et al.
Der Internist|December 7, 2007
[Female patient with organic psychosyndrome and neurological focal signs after immunosuppressant therapy]P Kühnlein, M Ringhoffer, H Tumani, et al.
Neuropathology and Applied Neurobiology|February 5, 2016
6-sulpho LacNAc(+) dendritic cells accumulate in various inflammatory, but not ischaemic conditions of the central nervous systemK Thomas, I Metz, H Tumani, et al.
Scientific Reports|June 6, 2019
Author Correction: Serum GFAP as a biomarker for disease severity in multiple sclerosisA Abdelhak, A Huss, J Kassubek, et al.
Deutsche Medizinische Wochenschrift (1946)|February 15, 2002
[Clinically atypical CJD: diagnostic relevance of cerebrospinal fluid markers and molecular genetic analysis?]H Tumani, O Windl, H A Kretzschmar, et al.
Journal of the Neurological Sciences|April 30, 1998
Acute optic neuritis: combined immunological markers and magnetic resonance imaging predict subsequent development of multiple sclerosis. The Optic Neuritis Study GroupH Tumani, W W Tourtellotte, J B Peter, et al.
Scientific Reports|October 6, 2018
Serum GFAP as a biomarker for disease severity in multiple sclerosisA Abdelhak, A Huss, J Kassubek, et al.
Journal of Neurology|January 19, 2008
Gender-specificities in Alzheimer's disease and mild cognitive impairmentU Beinhoff, H Tumani, J Brettschneider, et al.
Acta Neuropathologica|March 1, 1997
Increased glutamine synthetase immunoreactivity in experimental pneumococcal meningitisA K Stringaris, W Brück, H Tumani, et al.
European Journal of Neurology|August 28, 2007
Early diagnosis of rhinocerebral mucormycosis by cerebrospinal fluid analysis and determination of 16s rRNA gene sequenceD Bengel, M Susa, H Schreiber, et al.
Pageof 9

Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Archives of Neurology|October 16, 1999
Glutamine synthetase in cerebrospinal fluid, serum, and brain: a diagnostic marker for Alzheimer disease?H Tumani, G Shen, J B Peter, et al.
Der Internist|December 7, 2007
[Female patient with organic psychosyndrome and neurological focal signs after immunosuppressant therapy]P Kühnlein, M Ringhoffer, H Tumani, et al.
Neuropathology and Applied Neurobiology|February 5, 2016
6-sulpho LacNAc(+) dendritic cells accumulate in various inflammatory, but not ischaemic conditions of the central nervous systemK Thomas, I Metz, H Tumani, et al.
Scientific Reports|June 6, 2019
Author Correction: Serum GFAP as a biomarker for disease severity in multiple sclerosisA Abdelhak, A Huss, J Kassubek, et al.
Deutsche Medizinische Wochenschrift (1946)|February 15, 2002
[Clinically atypical CJD: diagnostic relevance of cerebrospinal fluid markers and molecular genetic analysis?]H Tumani, O Windl, H A Kretzschmar, et al.
Journal of the Neurological Sciences|April 30, 1998
Acute optic neuritis: combined immunological markers and magnetic resonance imaging predict subsequent development of multiple sclerosis. The Optic Neuritis Study GroupH Tumani, W W Tourtellotte, J B Peter, et al.
Scientific Reports|October 6, 2018
Serum GFAP as a biomarker for disease severity in multiple sclerosisA Abdelhak, A Huss, J Kassubek, et al.
Journal of Neurology|January 19, 2008
Gender-specificities in Alzheimer's disease and mild cognitive impairmentU Beinhoff, H Tumani, J Brettschneider, et al.
Acta Neuropathologica|March 1, 1997
Increased glutamine synthetase immunoreactivity in experimental pneumococcal meningitisA K Stringaris, W Brück, H Tumani, et al.
European Journal of Neurology|August 28, 2007
Early diagnosis of rhinocerebral mucormycosis by cerebrospinal fluid analysis and determination of 16s rRNA gene sequenceD Bengel, M Susa, H Schreiber, et al.
Pageof 9